Friday, 30 September 2022

SIRO Clinpharm, JRF to offer end-to-end drug development solution

08 September 2021 | News

The agreement is likely to boost SIRO’s presence across geographies

Image Credit: Shutterstock

Image Credit: Shutterstock

Mumbai-based clinical research organisation SIRO Clinpharm has announced an agreement with Jai Research Foundation (JRF), a Vapi-based contract research organisation, with an expansive portfolio of non-clinical regulatory research services to provide pre-clinical offerings.

 

With this second strategic partnership, SIRO has now expanded its offering portfolio by providing end-to-end services. Last year in June 2020, the company had announced its first strategic partnership with Azidus to expand combined services offerings and avail access to an expanded client base for technical requisites of pharma and biotech industries.

 

Commenting on the agreement, Akshay Daftary, Director, SIRO Clinpharm said, “The agreement would boost SIRO’s presence across geographies like Japan, the EU, LatAm countries, Canada, and the US.”

 

“With this agreement, both the companies stand to benefit, with their pooled mutual scientific talent and their capabilities to offer comprehensive solutions to their mutual sponsors,” said Dr Sameer Navalgund, Director, JRF-Global.

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account